Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Azacitidine
  • Hematopoietic Stem Cell Transplantation
  • Leukemia

abstract

  • There was a high response rate with low treatment-related mortality, with 26% of patients alive in remission 3.3 years after transplantation.

publication date

  • March 2003

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.11184

PubMed ID

  • 12599231

Additional Document Info

start page

  • 1242

end page

  • 7

volume

  • 97

number

  • 5